Education
About Us
Working with TipRanks
Follow Us
Werewolf Therapeutics (HOWL)
NASDAQ:HOWL
HOWL Analyst Ratings
Strong Buy
5 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
HOWL Stock 12 Month Forecast
Average Price Target
$8.20
▲(535.66%Upside)
| Highest Price Target$12.00 | Average Price Target$8.20 | Lowest Price Target$4.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TipRanks
$1
Hold
-22.48%
Downside
Reiterated
06/12/25
Werewolf Therapeutics' overall stock score is primarily impacted by its challenging financial performance, characterized by ongoing losses and negative cash flows. While technical analysis suggests some short-term momentum, valuation concerns and the risk of delisting due to the Nasdaq deficiency notice weigh on the score. However, progress in clinical trials and optimistic analyst ratings offer potential future upside, though they have yet to materially improve the company's financial position.
Bank of America Securities
$10→$9
Buy
597.67%
Upside
Reiterated
05/27/25
H.C. Wainwright
$15→$10
Buy
675.19%
Upside
Reiterated
05/09/25
Wedbush
$8→$6
Buy
365.12%
Upside
Reiterated
05/09/25
Leerink Partners
$13→$12
Buy
830.23%
Upside
Reiterated
05/09/25
Citizens JMP
$4
Buy
210.08%
Upside
Reiterated
04/21/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TipRanks
$1
Hold
-22.48%
Downside
Reiterated
06/12/25
Werewolf Therapeutics' overall stock score is primarily impacted by its challenging financial performance, characterized by ongoing losses and negative cash flows. While technical analysis suggests some short-term momentum, valuation concerns and the risk of delisting due to the Nasdaq deficiency notice weigh on the score. However, progress in clinical trials and optimistic analyst ratings offer potential future upside, though they have yet to materially improve the company's financial position.
Bank of America Securities
$10→$9
Buy
597.67%
Upside
Reiterated
05/27/25
H.C. Wainwright
$15→$10
Buy
675.19%
Upside
Reiterated
05/09/25
Wedbush
$8→$6
Buy
365.12%
Upside
Reiterated
05/09/25
Leerink Partners
$13→$12
Buy
830.23%
Upside
Reiterated
05/09/25
Citizens JMP
$4
Buy
210.08%
Upside
Reiterated
04/21/25
Best Analysts Covering Werewolf Therapeutics
1 Month
xxx
Success Rate
10/18 ratings generated profit
Average Return
+2.16%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 55.56% of your transactions generating a profit, with an average return of +2.16% per trade.
3 Months
xxx
Success Rate
8/16 ratings generated profit
Average Return
-2.86%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of -2.86% per trade.
1 Year
Success Rate
5/12 ratings generated profit
Average Return
+0.27%
reiterated a buy rating 19 days ago
Copying Jason Zemansky's trades and holding each position for 1 Year would result in 41.67% of your transactions generating a profit, with an average return of +0.27% per trade.
2 Years
xxx
Success Rate
3/16 ratings generated profit
Average Return
-39.44%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 18.75% of your transactions generating a profit, with an average return of -39.44% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
HOWL Analyst Recommendation Trends
Rating
Nov 24
Jan 25
Mar 25
Apr 25
May 25
Strong Buy
8
8
11
8
10
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
8
8
11
8
10
Each month's total comprises the sum of three months' worth of ratings.
HOWL Financial Forecast
HOWL Stock Forecast FAQ
What is HOWL’s average 12-month price target, according to analysts?
Based on analyst ratings, Werewolf Therapeutics’s 12-month average price target is 8.20.
What is HOWL’s upside potential, based on the analysts’ average price target?
Werewolf Therapeutics has 535.66% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is HOWL a Buy, Sell or Hold?
Werewolf Therapeutics has a consensus rating of Strong Buy which is based on 5 buy ratings, 0 hold ratings and 0 sell ratings.
What is Werewolf Therapeutics’s price target?
The average price target for Werewolf Therapeutics is 8.20. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $12.00 ,the lowest forecast is $4.00. The average price target represents 535.66% Increase from the current price of $1.29.
The highest analyst price target is $12.00 ,the lowest forecast is $4.00. The average price target represents 535.66% Increase from the current price of $1.29.
What do analysts say about Werewolf Therapeutics?
Werewolf Therapeutics’s analyst rating consensus is a Strong Buy. This is based on the ratings of 5 Wall Streets Analysts.
How can I buy shares of HOWL?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.